Scientist discovers why drug boosts memory in Down syndrome mice
November 24, 2011 in Medical research
(Medical Xpress) -- A University of Colorado School of Medicine researcher who found a drug that improved memory in mice with Down syndrome has unlocked the mystery of how it works.
In a new study published in Learning & Memory, Alberto Costa, MD, Ph.D., Associate Professor of Medicine and Neuroscience, and Graduate Assistant Jonah Scott-McKean found the mechanism behind excessive levels of long-term synaptic depression, or LTD, in mice with Down syndrome. LTD makes transmission of messages along the brains synapses more difficult and is frequently referred to as a mechanism for forgetting.
The study proposes that the excess LTD is likely caused by the overrepresentation of a limited subset of genes contained in the extra chromosome carried by these mouse models of Down syndrome. The investigators also found that when the drug memantine was administered to these mice at doses similar to those used to treat Alzheimers disease, LTD levels fell significantly. Therefore, Costa and Scott-McKean hypothesize that similar phenomena might also occur in the brains of persons with Down syndrome.
"We found the mechanism by which LTD is exaggerated in a mouse model of Down syndrome," Costa said. "We wanted to see if memantine would normalize the brain function of these mice. We found that the drug brings this important physiological parameter associated to learning and memory ice to near normal levels."
Costa found that this exaggerated LTD in Down syndrome mice does not share the same cellular mechanism as a similar phenomenon seen in a mouse that mimics the human disorder known as fragile X syndrome, which is the second most common form of intellectual disability of genetic origin. Costa had earlier discovered that memantine, currently used to treat patients with Alzheimers disease, improved memory in mice with Down syndrome but exactly how was unclear. He recently completed the data collection phase of a clinical trial using the drug on about 40 people with Down syndrome. The results have not yet been published.
"This will help us develop rational therapies for different intellectual disabilities. For example, based on these findings, it is probably unlikely that certain compounds that are currently being tested for the treatment of fragile X would work in persons with Down syndrome and, conversely, it is unlikely that a drug like memantine might be of any help in the improvement of cognition of young individuals with fragile X" he said. "It will also help us in the planning of clinical trials and represents another move toward more personalized therapies."
Provided by University of Colorado Denver
-
Scientist tests promising drug on those with Down syndrome
Aug 02, 2011 |
not rated yet |
0
-
Researcher finds altered cerebella in those with Down syndrome
Aug 24, 2011 |
not rated yet |
0
-
Drug shows promise for Down syndrome
Feb 26, 2007 |
not rated yet |
0
-
Researchers restore memory process in most common form of mental disability
Oct 05, 2007 |
not rated yet |
0
-
New clue found for Fragile X syndrome-epilepsy link
Apr 12, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Study reveals new mechanism for estrogen suppression of liver lipid synthesis
By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.
Medical research
May 23, 2013 |
5 / 5 (1) |
0
|
MRI-based measurement helps predict vascular disease in the brain
Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue the journal ...
Medical research
May 23, 2013 |
not rated yet |
0
Antibiotics: A new understanding of sulfonamide nervous system side effects
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
Medical research
May 23, 2013 |
3 / 5 (1) |
0
|
Scientists discover molecule triggers sensation of itch
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
Medical research
May 23, 2013 |
5 / 5 (3) |
0
|
Discarded immune cells induce the relocation of stem cells
Spanish researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today ...
Medical research
May 23, 2013 |
5 / 5 (2) |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.